Deals
Pfizer’s Zoetis Surges in Trading After $2.24 Billion IPO
This article is for subscribers only.
Zoetis Inc., the animal-health company owned by Pfizer Inc., surged 19 percent in its debut after raising $2.24 billion in an initial public offering, pricing the shares above the proposed range.
The shares climbed to $31.01 at 4 p.m. New York time. Zoetis yesterday sold 86.1 million shares at $26 each, after offering them for $22 to $25.